Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

por Lu, Fangliang, Li, Shaolei, Dong, Bin, Zhang, Shanyuan, Lv, Chao, Yang, Yue
Publicado 2015

Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study

por Lv, Chao, Ma, Yuanyuan, Feng, Qin, Lu, Fangliang, Chi, Yongkun, Wu, Nan, Fang, Jian, Yang, Yue
Publicado 2020

Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

por Huang, Miao, Ma, Yuanyuan, Lv, Chao, Li, Shaolei, Lu, Fangliang, Zhang, Shanyuan, Wang, Daisy Dandan, Lin, Peter Ping, Yang, Yue
Publicado 2021

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study

por Huang, Zekai, Li, Shaolei, Yang, Xin, Lu, Fangliang, Huang, Miao, Zhang, Shanyuan, Xiong, Ying, Zhang, Panpan, Si, Jiahui, Ma, Yuanyuan, Yang, Yue
Publicado 2019

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma

por Li, Junfeng, Li, Jianjie, Hao, Huifeng, Lu, Fangliang, Wang, Jia, Ma, Menglei, Jia, Bo, Zhuo, Minglei, Wang, Jingjing, Chi, Yujia, Zhai, Xiaoyu, Wang, Yuyan, Wu, Meina, An, Tongtong, Zhao, Jun, Yang, Fan, Wang, Ziping
Publicado 2023

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung

por Feng, Yuan, Sun, Wei, Zhang, Jie, Wang, Yang, Chen, Jinfeng, Liu, Xinying, Wang, Liang, Li, Shaolei, Lv, Chao, Lu, Fangliang, Zhang, Jianzhi, Hong, Yang, Xiao, Shanshan, Wang, Tao, Jiao, Raymond, Wang, Ziping, Qi, Liping, Li, Nan, Yang, Yue, Lin, Dongmei, Fang, Jian
Publicado 2021